These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31867054)

  • 21. Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke.
    Barlas RS; Loke YK; Mamas MA; Bettencourt-Silva JH; Ford I; Clark AB; Bowles KM; Metcalf AK; Potter JF; Myint PK
    Am J Cardiol; 2018 Sep; 122(6):1085-1090. PubMed ID: 30072125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monotherapy with a P2Y
    Chiarito M; Sanz-Sánchez J; Cannata F; Cao D; Sturla M; Panico C; Godino C; Regazzoli D; Reimers B; De Caterina R; Condorelli G; Ferrante G; Stefanini GG
    Lancet; 2020 May; 395(10235):1487-1495. PubMed ID: 32386592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicenter Registry.
    Lee HL; Kim JT; Lee JS; Park MS; Choi KH; Cho KH; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Sun Oh M; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Lee J; Bae HJ
    Circ Cardiovasc Qual Outcomes; 2020 Nov; 13(11):e006474. PubMed ID: 33201737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Effects of Dual Antiplatelet Therapy or Aspirin Monotherapy after Acute Minor Ischemic Stroke or Transient Ischemic Attack, a Meta-Analysis.
    Condello F; Liccardo G; Ferrante G
    Curr Pharm Des; 2021; 27(40):4140-4146. PubMed ID: 34323179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II.
    Kitagawa K; Toyoda K; Kitazono T; Nishikawa M; Nanto S; Ikeda Y; Abe K; Ogawa A
    Cerebrovasc Dis; 2020; 49(2):152-159. PubMed ID: 32208397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or Transient Ischemic Attack.
    Rahman H; Khan SU; Nasir F; Hammad T; Meyer MA; Kaluski E
    Stroke; 2019 Apr; 50(4):947-953. PubMed ID: 30852971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
    Tillman H; Johnston SC; Farrant M; Barsan W; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Easton JD
    JAMA Neurol; 2019 Jul; 76(7):774-782. PubMed ID: 31034032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke.
    Gao Y; Chen W; Pan Y; Jing J; Wang C; Johnston SC; Amarenco P; Bath PM; Jiang L; Yang Y; Wang T; Han S; Meng X; Lin J; Zhao X; Liu L; Zhao J; Li Y; Zang Y; Zhang S; Yang H; Yang J; Wang Y; Li D; Wang Y; Liu D; Kang G; Wang Y; Wang Y;
    N Engl J Med; 2023 Dec; 389(26):2413-2424. PubMed ID: 38157499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Stroke; 2017 Sep; 48(9):2610-2613. PubMed ID: 28701574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis.
    Xie W; Zheng F; Zhong B; Song X
    J Am Heart Assoc; 2015 Aug; 4(8):e002259. PubMed ID: 26304937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
    JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY;
    N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone.
    Hong KS; Lee SH; Kim EG; Cho KH; Chang DI; Rha JH; Bae HJ; Lee KB; Kim DE; Park JM; Kim HY; Cha JK; Yu KH; Lee YS; Lee SJ; Choi JC; Cho YJ; Kwon SU; Kim GM; Sohn SI; Park KY; Kang DW; Sohn CH; Lee J; Yoon BW;
    Stroke; 2016 Sep; 47(9):2323-30. PubMed ID: 27418597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short- vs. long-term dual antiplatelet therapy in secondary prevention for ischaemic stroke: a network metanalysis.
    Pugliese F; Arasaratnam P; Moellenberg M; Dani S
    Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):298-309. PubMed ID: 31050716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.
    Del Giovane C; Boncoraglio GB; Bertù L; Banzi R; Tramacere I
    BMC Neurol; 2021 Aug; 21(1):319. PubMed ID: 34399713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack-Protocol for a systematic review and network meta-analysis.
    Zitikyte G; Roy DC; Dhaliwal S; Lun R; Hutton B; Shorr R; Dowlatshahi D
    PLoS One; 2021; 16(4):e0250553. PubMed ID: 33909676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
    Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
    Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
    Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
    Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early Secondary Prevention in Transient Ischemic Attack (TIA) and Minor Stroke.
    Tse D; Hill MD; Coutts SB
    Curr Neurol Neurosci Rep; 2019 May; 19(6):34. PubMed ID: 31089960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.